Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Warby Parker's EV-to-EBIT or its related term are showing as below:
MEX:WRBY'
s EV-to-EBIT Range Over the Past 10 Years
Min: -656.8 Med: -25.39 Max: 2343.87
Current: 2076.54
During the past 7 years, the highest EV-to-EBIT of Warby Parker was 2343.87. The lowest was -656.80. And the median was -25.39.
MEX:WRBY's EV-to-EBIT is ranked worse than 99.58% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 19.01
vs MEX:WRBY: 2076.54
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Warby Parker's Enterprise Value for the quarter that ended in Jun. 2026 was MXN45,736 Mil.
Warby Parker's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Warby Parker EV-to-EBIT Related Terms
Warby Parker EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Warby Parker's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:WRBY vs XRAY, LMAT, PLSE: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Warby Parker's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Warby Parker EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Warby Parker's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Warby Parker's EV-to-EBIT falls into.
Warby Parker's current Enterprise Value is MXN55,254 Mil.
Warby Parker's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Warby Parker (MEX:WRBY) has a EV-to-EBIT of 2,013.91 as of Aug. 11, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Warby Parker and its competitors. According to the industry distribution chart, Warby Parker ranks #471 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 99.6%.
Is Warby Parker's EV-to-EBIT too high?
Warby Parker's current EV-to-EBIT is 2,013.91. The Medical Devices & Instruments industry median EV-to-EBIT is 19.01. Warby Parker's value of 2,013.91 is 10494% above this industry median. Based on the distribution chart, Warby Parker ranks #471 out of 473 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Warby Parker has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Warby Parker's EV-to-EBIT compare to XRAY and LMAT?
According to the Medical Devices & Instruments industry distribution chart, Warby Parker ranks #471 out of 473 companies for EV-to-EBIT. This places Warby Parker in the lower half of its industry. The industry median EV-to-EBIT is 19.01. Warby Parker's value of 2,013.91 is 10494% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.01, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Warby Parker's current EV-to-EBIT of 2,013.91 is 10494% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Warby Parker and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Warby Parker's current EV-to-EBIT is 2,013.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Warby Parker stock overvalued right now?
Warby Parker (MEX:WRBY) has a current EV-to-EBIT of 2,013.91. The stock's GF Value™ is MXN302.34, compared to a current price of MXN369.50 — trading 22.2% above its estimated fair value. The current EV-to-EBIT is 2,013.91 and 10494% above the Medical Devices & Instruments industry median of 19.01. Warby Parker's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Warby Parker (MEX:WRBY), the current EV-to-EBIT is 2,013.91 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Warby Parker (MEX:WRBY) Overvalued in 2026?
Based on GuruFocus' analysis, Warby Parker stock appears to be overvalued.
The current stock price of MXN369.50 is trading 22.2% above its estimated GF Value™ of MXN302.34.
Key valuation signals for MEX:WRBY:
EV-to-EBIT: 2,013.91
GF Value™: MXN302.34 vs. price of MXN369.50 (22.2% above fair value)
Industry Position: 10494% above the Medical Devices & Instruments median (#471 of 473)
No single metric tells the full story. See the MEX:WRBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
69GF Score
Get the complete analysis for MEX:WRBY
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:WRBY has been successfully added to your 
